John Fanning, MD
Foot and Ankle Surgery · Wichita, KSNPI 1306813571
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Titan Surgical Group, LLC at 28.1% of the total. Reporting peaked in 2023 at $2,076 and has fallen 59.2% since, to $847 in 2025.
Across 76 payments — averaging $80.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$2K
- Arthrex$2K
- Treace Medical Concepts, Inc.$1K
- Stryker$789
- Bard Peripheral Vascular, Inc.$236
- Acumed LLC$150
- plus $89 from 5 others
What the payments were for
- Travel & lodging$3,60459%
- Food & beverage$2,53341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 10 | $1,727 |
| Arthrex | 21 | $1,697 |
| Treace Medical Concepts, Inc. | 12 | $1,451 |
| Stryker(2 entities) | 11 | $789 |
| Bard Peripheral Vascular, Inc. | 15 | $236 |
| Acumed LLC | 2 | $150 |
| Lima USA, Inc. | 1 | $25 |
| Smith+Nephew | 1 | $21 |
| Arthrosurface Incorporated | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $15 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$692
- LAPIPLASTY SYSTEM 1$251
- TMC NANOPLASTY SYSTEM$153
- ACUMED$128
- InFrame Implant$128
- ORTHOLOC$122
- CITREFIX$117
- 7 X 23MM CITRELOCK IMPLANT$117
- DART-FIRE$103
- ALLOPURE$103
How this compares
$6,138 in reported general payments places this provider in the 70th percentile of 40 foot and ankle surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $622 |
| Ondansetron OdtOndansetron | 36 | $179 |
| Doxycycline Hyclate | 12 | $152 |
| Cyclobenzaprine Hcl | 33 | $144 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $108 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Wichita
- David SanchezWichita$6K
- Shawn MorrowWichita$3K
- Steven HowellWichita$2K
- Jon MorganWichita$1K
- Kent HeadyWichita$799
- Greg HortonKansas City$1.1M
- Melissa JournotLeawood$26K
- Zhipeng YangKansas City$25K
- Patrick McGregorLawrence$24K
- Andrea DrielingHutchinson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.